Systematic review and meta-analysis of prognostic factors for early recurrence in intrahepatic cholangiocarcinoma after curative-intent resection

WJ Choi, PJ Williams, MPAW Claasen, T Ivanics… - Annals of surgical …, 2022 - Springer
Background Recurrence rates of intrahepatic cholangiocarcinoma (iCCA) after curative
hepatectomy are as high as 50% to 70%, and about half of these recurrences occur within 2 …

[HTML][HTML] The management of post-transplantation recurrence of hepatocellular carcinoma

L Rajendran, T Ivanics, MPAW Claasen… - Clinical and …, 2022 - ncbi.nlm.nih.gov
The annual incidence of hepatocellular carcinoma (HCC) continues to rise. Over the last
two decades, liver transplantation (LT) has become the preferable treatment of HCC, when …

Recipient and donor outcomes after living-donor liver transplant for unresectable colorectal liver metastases

…, S Gallinger, N Selzner, MPAW Claasen… - JAMA …, 2022 - jamanetwork.com
Importance Colorectal cancer is a leading cause of cancer-related death, and nearly 70% of
patients with this cancer have unresectable colorectal cancer liver metastases (CRLMs). …

The Toronto postliver transplantation hepatocellular carcinoma recurrence calculator: a machine learning approach

…, W Nelson, MS Patel, MPAW Claasen… - Liver …, 2022 - Wiley Online Library
Liver transplantation (LT) listing criteria for hepatocellular carcinoma (HCC) remain
controversial. To optimize the utility of limited donor organs, this study aims to leverage machine …

Dynamic risk profiling of HCC recurrence after curative intent liver resection

T Ivanics, CF Murillo Perez, MPAW Claasen… - …, 2022 - Wiley Online Library
Background and Aims Following liver resection (LR) for HCC, the likelihood of survival is
dynamic, in that multiple recurrences and/or metastases are possible, each having variable …

Toronto management of initially unresectable liver metastasis from colorectal cancer in a living donor liver transplant program

L Rajendran, MPAW Claasen… - Journal of the …, 2023 - journals.lww.com
BACKGROUND: Living donor liver transplantation (LDLT) is an attractive option for patients
with unresectable, bilobar colorectal liver metastases (CRLM). However, it is not available in …

Low utilization of adult-to-adult LDLT in Western countries despite excellent outcomes: International multicenter analysis of the US, the UK, and Canada

T Ivanics, D Wallace, MPAW Claasen, MS Patel… - Journal of …, 2022 - Elsevier
Background & Aims Adult-to-adult living donor liver transplantation (LDLT) offers an
opportunity to decrease the liver transplant waitlist and reduce waitlist mortality. We sought to …

[HTML][HTML] An international multicentre evaluation of treatment strategies for combined hepatocellular-cholangiocarcinoma✰

MPAW Claasen, T Ivanics, BR Beumer, RF de Wilde… - JHEP Reports, 2023 - Elsevier
Background & Aims Management of combined hepatocellular-cholangiocarcinoma (cHCC-CCA)
is not well-defined. Therefore, we evaluated the management of cHCC-CCA using an …

Living Donor Liver Transplantation for Hepatocellular Carcinoma Within and Outside Traditional Selection Criteria: A Multicentric North American Experience

T Ivanics, MPAW Claasen, B Samstein… - Annals of …, 2024 - journals.lww.com
Objective: To evaluate long-term oncologic outcomes of patients post–living donor liver
transplantation (LDLT) within and outside standard transplantation selection criteria and the …

Trends in indications and outcomes of liver transplantation in Canada: a multicenter retrospective study

T Ivanics, C Shwaartz, MPAW Claasen… - Transplant …, 2021 - Wiley Online Library
The liver transplantation (LT) landscape is continuously evolving. We sought to evaluate
trends in indications for LT in Canada and the impact of primary liver disease on post‐LT …